Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells by STEPHENS, R et al.
 
20
 
© 2009 The Authors
Journal compilation © 2009 Blackwell Publishing Ltd
 
Parasite Immunology
 
,
 
 
 
2009, 
 
31
 
, 20–31 DOI: 10.1111/j.1365-3024.2008.01066.x
 
Blackwell Publishing Ltd
 
ORIGINAL ARTICLE
 
Memory B cell reactivation in mouse malaria
 
Germinal centre and marginal zone B cells expand quickly in 
a second 
 
Plasmodium chabaudi
 
 malaria infection producing mature 
plasma cells
 
R. STEPHENS, F. M. NDUNGU & J. LANGHORNE
 
National Institute for Medical Research, Division of Parasitology, The Ridgeway, Mill Hill, London NW7 1AA, UK
 
SUMMARY
 
Antibodies and B cells are critical in the protective immune
response to the blood stage of the malaria parasite, 
 
Plasmodium
chabaudi. 
 
However, little is known about the development of
memory B cells and their differentiation into plasma cells during
infection or after re-infection. Here we have shown that B cells
with phenotypic characteristics of memory cells (CD19
 
+
 
IgD
 
–
 
CD38
 
+
 
, IgG1
 
+
 
) are generated in a primary 
 
Plasmodium
chabaudi chabaudi
 
 infection of mice. In addition, we observed
that germinal centre cells (CD19
 
+
 
, GL7
 
+
 
, MHCII
 
hi
 
) and
Marginal Zone B cells (CD19
 
+
 
CD23
 
−
 
IgD
 
−
 
) show faster
expansion on re-infection than in the primary, though other
subsets do not. Interestingly, though both IgM
 
–
 
  and IgM
 
+
 
memory cells are produced, IgM
 
+
 
 memory cells do not expand
on second infection. The second infection quickly produced
mature bone marrow plasma cells (intracellular Ig
 
hi
 
, CD138
 
hi
 
,
CD9
 
+
 
, B220
 
–
 
), compared to primary infection; which generates
a very large population of immature splenic plasma cells
(B220+). This analysis suggests that a memory B cell
population is generated after a single infection of malaria,
which on re-infection responds quickly producing germinal
centres and generating long-lived plasma cells making the
second encounter with parasite more efﬁcient.
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INTRODUCTION
 
Immunity to malaria is slow to develop, and although
prevalence and levels of parasitaemia decrease with exposure,
susceptibility to re-infection remains for years even after
repeated exposure (1,2). This may be due to extensive
antigenic variation of the parasite (3) and strain-speciﬁc
immunity. However, susceptibility to repeat infections and
short-lived protection from pathology may also result from
inherent or malaria-speciﬁc limitations of immunological
memory and protective immunity (1). Antibodies are
considered to be a major effector mechanism eliminating
blood-stage malaria parasites in humans (4,5), and in experi-
mental models (6,7), and it is therefore possible that
impairment of protective immunity is due to defects in the
B cell response. Most of our information to date on the B
cell response in both human and experimental infections
has come from analysis of antimalaria antibodies in sera.
While there are many studies documenting the levels,
isotype and duration of the antibody responses (reviewed in
Ref. (8)), there are very few cellular studies investigating the
nature and development of the antibody-producing cells;
B cells and plasma cells. Those studies, describing large
short-lived polyclonal B cell responses (9–11), changes in
splenic microarchitecture (12) and B cell compartments
such as germinal centres (13), and deletion of malaria-
speciﬁc B cells after acute infection (14), suggest that the B
cell response and resulting memory to 
 
Plasmodium
 
 may be
impaired. However, 
 
Plasmodium chabaudi
 
 infection in mice
does stimulate signiﬁcant malaria-speciﬁc antibody responses,
and we have shown that kinetics of MSP-1 speciﬁc antibody
production on re-challenge are enhanced, a result compatible
with the normal generation of memory B cells (15). Studies
of the nature of the plasma cell response will be important
to discern reasons for the short-lived components of the
antibody response to human malaria (8).
Although the exact role for antigen, or pathogen persistence
in the humoral memory response is still a matter of debate
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(16–20), immunity appears to be enhanced in malaria and
other infections by pathogen persistence (21–24), suggesting
that B cell responses in malaria could be altered by chronic
infection. Persistent, low-level parasitaemia following acute
infection for up to 3 months is a feature of
 
 P. chabaudi
 
 infection
of mice (15), and in this respect is similar to some human
infections. The chronic phase of primary infection has been
shown to affect both the magnitude of the challenge infection,
and the secondary antibody response (15), and so may well
have affects on the nature and magnitude of a secondary
B cell response. Thus this model may provide some clues
about the effects of persistent parasites on the B cell
response, which could be applicable to human infection.
A detailed study of the types of B cells activated and
plasma cells generated and maintained in this model may
help to deﬁne the nature of the B cell response and identify
populations of antibody-producing cells that are activated
and maintained in infection. Therefore, in this study, we
have characterized subsets of B cells and plasma cells in
primary and challenge infections with 
 
Plasmodium chabaudi
 
,
and have investigated the effect of persistent infection on
these subsets. We show here that previously activated B cells
and plasma cells survive for 2 months after infection, even
after the chronic infection has been eliminated with
chloroquine. After re-challenge, in contrast to the primary
infection, there is an enhanced B cell response, a greater pro-
portion of mature plasma cells; and splenomegaly and bone
marrow depletion are minimal. These data suggest that
there is a more focused and efﬁcient secondary response to
the parasite, consistent with a memory response.
 
MATERIALS AND METHODS
 
Mice and parasites
 
C57Bl/6 mice were bred in the National Institute for
Medical Research under SPF conditions and for experiments
maintained conventionally with sterile food and irradiated
water 
 
ad libitum
 
. All experiments conducted under British
Home Ofﬁce regulations. Female 5–8-week-old mice were
infected with 10
 
5
 
 parasitized erythrocytes from 
 
P.  chabaudi
chabaudi 
 
(AS) infected mice, and monitored by examination
of Giemsa-stained blood ﬁlms as described previously (25).
Chronic infection was eliminated by three i.p. injections of
50  mg chloroquine (Sigma, UK)/kg body weight (average
20 g) in 0·9% saline solution at 2-day intervals, from day 30
of infection. This clone of 
 
P. chabaudi
 
 is sensitive to chloro-
quine when used at low parasite density ((26) and W. Jarra,
personal communication); after treatment no parasites were
detectable by thin or thick blood ﬁlm analysis or after
sub-inoculation of blood into naïve recipients (15). Primary
and secondary infections were conducted simultaneously
with age-matched uninfected controls and oldest uninfected
mice are shown as day 0.
 
Antibodies and ﬂow cytometric analysis
 
Spleens or bone marrow cells from femurs and tibias, were
collected and dissociated into single cells in HBSS (Gibco, UK)
containing 5% FBS (Seralabs, UK) and 6 m
 

 
 HEPES. Erythro-
cytes were lysed using hypotonic lysis solution (Sigma). Cells
were counted (Scharfe System CASY1, Reutlingen, Germany).
Subset numbers were calculated by multiplying the percentage
of lymphocytes by total number of viable nucleated cells.
Cells were stained at 3 
 
×
 
 10
 
6
 
/well in 96-well V-bottom
plates and incubated with anti-CD16/32(24G2) at 37
 
°
 
C for
20 min, followed by 20 min at 4
 
°
 
C to eliminate surface
binding of endogenous antibody. After washing, cells were
incubated in PBS with 2% FCS and 0·01% Sodium azide
and indicated combinations of FITC-, PE-, PerCP, TriColor-,
biotin- or allophycocyanin- (APC)-conjugated antibodies
with Strepdavidin -FITC or -APC (BD Biosciences, Cambridge
Biosciences Oxford, UK). After washing, cells were ﬁxed
overnight with 2% paraformaldehyde in PBS. CD138/syndecan-
1(281-2), stains were performed in PBS, 1% BSA. For
intracellular staining, after surface staining, cells were ﬁxed
with PharMingen Cytoﬁx/Cytoperm solution (BD Biosciences).
Fixed cells were permeabilized by washing in Perm/Wash
buffer (BD Biosciences) twice and 20-min incubation. Cells
were  stained with goat antimouse-IgG plus IgM-FITC
(antiserum, multiply adhered, BD Biosciences) at 70 
 
µ
 
g/
 
µ
 
L
for 3 
 
×
 
 10
 
6
 
 cells for 40 min. Cells were washed thrice in Perm/
Wash buffer and re-suspended in staining buffer. A total of
30 000 lymphocytes or 1–2 million events were collected
for rare cells. Data acquired on a FACS calibur using Cell
Quest Pro (Becton Dickenson) and analysed using FlowJo
(Portland, OR). For all analyses, cells were ﬁrst gated by
forward and side scatter properties for the characteristics of
lymphocytes as shown in Figure 1(c). Plasma cell live gate
includes larger cells, but not granulocytes, as some plasma
cells are found near the top of the SSC scale. Stains done on
different days were synchronized for analysis by equalizing
gates in uninfected mice. Plasma cells gated on intracellular
IgG/M were drawn after analysing surface staining. Mean
ﬂuorescence intensity of surface staining was a log lower
than intracellular staining in CD138
 
hi
 
CD9
 
+
 
B220
 
−
 
  plasma
cells and thus surface staining cells could be excluded.
 
Statistics
 
All experiments were analysed by one-way ANOVAs and
where differences were real, individual groups were studied
by Two-tailed, unpaired 
 
t
 
-tests and 
 
P 
 
≤
 
 0·05 considered
signiﬁcant (Prism, GraphPad San Diego, CA). 
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Figure 1 B cells are activated in P. chabaudi 
infection and produce memory phenotype 
cells. C57Bl/6 mice were infected with 105 
P. c. chabaudi, some were treated with 
chloroquine (CQ) days 30–34. Splenocytes 
were analysed by FACS and gated by 
forward and size scatter properties for the 
characteristics of lymphocytes. On various 
days of infection, splenocytes were stained 
for and gated on CD19-TC and 
(a) IgD-FITC or (b) CD23-PE, and CD21/
35-biotin or (c–e) CD19-TC, CD23-PE, 
CD21/35-biotin and IgM-APC. (c) Cells 
were gated as shown for quantitation of 
memory phenotype cells on CD19+, 
CD21−CD23− and IgM+ or IgM−. Day 60 
splenocytes are shown. (d) CD19+CD23−
CD21−IgM−, and (e) CD19+CD23−CD21−
IgM+ B cells are quantiﬁed for four 
months post-infection. (f) Splenocytes are 
stained for CD19-TC, IgD-biotin and 
CD38-FITC and gated on CD19+, as 
shown in (c, left, day 60). As shown, gates 
were set according to the levels of CD38 
and IgD on naive B cells (left), and memory 
B cells are quantiﬁed as CD38hi IgD-
CD19+ (right). Representative plots of ﬁve 
mice shown. 
© 2009 The Authors
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RESULTS
 
Persistence of previously activated and isotype-switched 
memory B cells in 
 
Plasmodium chabaudi
 
 infection
 
The kinetics of parasitaemia and the expansion of splenocytes
and B cells in a primary infection were investigated (Supple-
mentary Figure 1). In order to study B cell subpopulations
and plasma cells after primary
 
  P.  chabaudi 
 
infection, the
activation phenotype of B cells was investigated for four
months following infection (Figure  1a–e). As B cells are
activated, they down-regulate IgD expression and can then
differentiate into antibody-secreting cells, or switch isotypes
from IgM to IgG in the germinal centre. Down-regulation
of IgD on CD19
 
+
 
 splenocytes is shown in Figure 1(a). While
the percentage of IgD
 
−
 
 CD19
 
+
 
 B cells increased considerably
around day 25, the proportion of previously activated
IgD
 
−
 
 B cells was only slightly elevated at 2 months and back
to baseline by 4 months after infection (Figure 1a). Previously
activated B cells have lower levels of expression of the low
afﬁnity IgE receptor, CD23 (27,28). We observed that all
CD23
 
−
 
 B cells during acute infection were also negative for
the complement receptor-1/2 (CD21/35). We investigated
the generation and maintenance of activated B cells in
a time-course of CD19
 
+
 
CD21
 
−
 
CD23
 
−
 
  cells, Figure  1(b).
CD21
 
−
 
CD23
 
−
 
 B cells peak during infection, however, they
return to basal levels by 4 months after infection. The
percentage of IgM
 
-
 
, isotype-switched B cells changed
considerably from day 0 to day 60 (from 32% to 59%, IgM
 
−
 
,
data not shown), so we looked at IgM expression on
activated B cells. The gating is shown in Figure 1(c). While
IgM
 
−
 
 CD21
 
−
 
CD23
 
−
 
CD19
 
+
 
 B cells peak at day 21 and are
detectable until day 36 post-infection, IgM
 
+
 
 cells peak
earlier. This suggests that the IgM
 
+
 
 B cells switch isotypes
(Figure 1d,e), with IgM
 
+
 
 cells increasing ﬁrst in infection,
and IgM
 
-
 
  cells appearing dramatically around day 21.
Another marker of activation is CD38, which is reduced as
IgD is down-regulated on germinal centre B cells and is
re-expressed after the germinal centre (GC) reaction on
memory B cells (Bmem), but not mature plasma cells in
mice (29). In our experiments (Figure 1f), the proportion
of IgD
 
−
 
CD38
 
hi
 
, previously activated but resting memory
B cells within the CD19
 
+
 
  B cell population, increased
from d0 (1·52% CD19 
 
±
 
 0·07 SEM, 
 
n
 
 = 5) vs. d60 (4·18% ± 0·86,
 
n
 
 = 5).
To  investigate the immunoglobulin isotype on B cells in
this infection, we examined surface expression of IgG2a and
IgG1 on CD19
 
+
 
 IgD
 
−
 
 cells. By 20 days post-infection, a
dramatic increase in the proportion of IgG2a
 
b
 
 + B  cells
(22·9% of CD19
 
+
 
IgD
 
−
 
 in Figures 2a and 1·7 ± 0·05% of
Figure 2 Isotype prevalence changes throughout P. chabaudi infection and IgG1 memory cells survive. Mice were infected with P. chabaudi 
and splenocytes analysed by FACS. Density plots are gated on CD19-TC+IgD-FITC- B cells as shown in Figure 1a (LR quadrant). 
(a) IgG2a-biotin, IgG1-PE staining on various days. (b) Quantiﬁcation of B cells expressing IgG1 and IgG2a throughout infection. 
(c) IgG1-PE and CD23-biotin shows that the expanded IgG1+ population is CD23−. Error bars represent SEM of 3 (d75) -5 mice per group. 
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lymphocytes Figure 2b) was observed, which diminished by
day 45, when an IgG1
 
+
 
 population was detectable. Appro-
ximately 30% of remaining IgD
 
−
 
 B cells, two months after
infection, expressed IgM; however, isotype of the Ig on the
remaining CD19
 
+
 
IgD
 
−
 
 cells could not be determined. At day
60, a distinct population of IgG1
 
+
 
CD23
 
−
 
CD19
 
+
 
 previously
activated or memory B cells was observed (Figure 2c). The
appearance of IgG1
 
+
 
 cells after IgG2a agrees with earlier
observations on serum antibody kinetics in 
 
P.  chabaudi
 
infections, and coincides with the gradual increase in
malaria-speciﬁc IgG1 antibodies and T helper cell precursors
and the gradual decrease in IgG2a serum antibody and
IFN-
 
γ
 
 producing Th1 cells observed in this infection (30).
However, this analysis represents both malaria-speciﬁc and
bystander activation of B cells.
 
B cells respond differently in a second infection
 
We next examined the phenotype of B cells after a second
infection with 
 
P.  chabaudi
 
, to determine whether activation
or expansion of different subpopulations took place more
rapidly, as expected for a memory response. Since a primary
 
P. chabaudi
 
 infection in C57Bl/6 can remain chronic, at very
low levels, for up to 60 days, re-infection of mice in this time
superimposes a second infection over the existing chronic
primary infection. We therefore determined whether there
was a rapid expansion of the different B cell populations, a
deﬁning characteristic of an adaptive recall response, on second
challenge with 
 
P. chabaudi
 
 given to chronically infected mice
and to mice treated with chloroquine after the primary
infection to eliminate parasites. As described previously,
both groups of mice were partially immune to the second
infection, with lower secondary parasitaemias in re-
challenged, chronically infected mice (15). Although
splenomegaly is dramatic in the ﬁrst infection, there was
only a small increase in spleen cellularity following the
second infection (Figure 3a). Furthermore, while more than
50% of bone marrow cells are mobilized out of the bone
marrow at the peak of the ﬁrst infection, a second infection
does not seem to impact bone marrow cellularity (Figure 3b).
Activated and isotype-switched B cells (CD19+IgD−IgM−,
Figure 3c–f), as well as marginal zone and IgM+ memory B
cells (CD19+IgD−IgM+) were also measured after the second
infection (Figure 3c). As an indication of memory B cell
re-activation, the speed of the B cell response was compared
in the ﬁrst and second infections. The proportion of isotype-
switched B cells (%IgM-/IgD-CD19+) doubled at day 60
suggesting a change in the composition of the B cell pool
towards more isotype-switched cells (Figure 3d), however,
neither IgM+ nor IgM− IgD− B cell numbers were signiﬁcantly
increased at day 60 (Figure 3e,f). Interestingly, looking at
expansion from day 0 of primary or secondary (day 60)
infection, it is clear that upon re-challenge, the IgM−,
isotype-switched memory cells, but not the IgM+  IgD−
previously activated population expanded signiﬁcantly by
day 7 (Figure 3e,f). This may be explained by data showing
that expansion of IgM+  memory cells is inhibited by
signalling of antigen-speciﬁc IgG via their Fc Receptors
(31), or that these cells switch isotype quickly in the second
infection.
Dramatic reactivation of memory B cells in the germinal 
centre and marginal zone subsets in second infection
Measurement of germinal centre B cells was included in the
analysis of primary and secondary responses, as the germinal
centre (GC) is the site of the T-cell-dependent B cell
response, which includes expansion of antigen-speciﬁc
clones, afﬁnity maturation of the immunoglobulin receptor
and isotype switching, resulting in the generation of memory
B cells and plasma cells. Memory B cell re-activation can be
seen here by comparing B cell expansion in the germinal
centre in a ﬁrst infection to that in a second. Activated,
GL7+MHCIIhi, germinal centre B cells were measured at
day 0 and day 7 of the ﬁrst and second infection. The effect
of drug elimination of the primary infection on the secondary
B cell response was also compared (Figure 4). In a primary
infection, the numbers and proportions of germinal centre B
cells (CD19+GL7+) increased with kinetics similar to other
activated B cell subsets with a maximum of 8·9% (day
25 ± 1·8%) of all CD19+ B cells and returned to the level of
age-matched, uninfected mice by 90 days (data not shown).
While the germinal centre B cell population was not signiﬁ-
cantly above the levels of uninfected mice on day 7 in the
primary infection (Figure 4a,b), expansion of GL7+MHCIIhi
B cells was signiﬁcantly greater in a second infection, as seen
on day 7 (Figure 4a–c), with an increase in both the percentage
of GL7+ cells and an almost fourfold increase in numbers
(Figure  4b,c), suggesting an adaptive memory response.
Figure 4d–f show this increase in B cell activation in the
challenge infection using the phenotype CD38−IgD−  to
identify germinal centre B cells. CD38 is down-regulated on
activation and returns to normal levels on memory B cells
(29) and identiﬁes activated B cells slightly earlier than GL7.
CD38 down-regulation shows a dramatic difference between
the ﬁrst and second infection in percent (Figure 4d,e) and
numbers (Figure  4f) and a dramatically increased rate of
expansion can be seen in Germinal Centre B cell population
in the second infection (Figure 4c,f). The increase in germinal
centre cells in second infection was not due to increased
levels of antigen, as on day 7 of a second infection, parasi-
taemia was one to two orders of magnitude lower than in a
primary infection (15). Chloroquine treatment at 30  days
post-primary infection did not affect numbers or proportions© 2009 The Authors 25
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of GC B cells before re-challenge (d60), but at day 7 after
re-infection there was a lower percentage and number of GC
B cells (Figure 4b,c, P = 0·02, and 0·03, respectively) in the
drug-treated mice.
As the Marginal Zone also contains memory B cells, it
was important to ascertain their participation in the second
infection. Marginal Zone B cells can be detected using
CD23 and IgD down-regulation. While CD23 is much less
down-regulated overall on B cells in second infection
(Figure 5a, left quadrants), there is a stronger expansion of
CD23–IgD– B cells on re-challenge (Figure 5a–c). There was
no signiﬁcant difference in marginal zone B cell numbers,
measured as either IgM+IgD− or CD23–IgD– B cells between
drug-treated or chronically infected mice.
Figure 3 Increase in proportion of isotype-switched B cells after infection and lack of re-expansion of IgM+IgD– B cells. Mice were infected 
and some were treated with chloroquine (CQ) days 30–34 post-infection. Two months post-infection, they were re-infected and analysed 7 days 
later (2o d7). (a) Splenocytes and (b) Bone marrow cells were counted during the course of a ﬁrst or second infection (c) Splenocytes were 
stained and analysed by FACS for CD19-TC, IgD-biotin, and IgM-PE on days 0, 60 and 7 (not shown) of the primary and secondary 
infection. Plots are gated on CD19, as shown in Figure 1C and (c) Percent of total CD19+ cells is shown. (d) Percent of activated B cells, 
CD19+IgD– that are isotype switched, IgM– and (e) numbers of isotype switched, IgM−IgD− and (f) non-isotype switched, but previously 
activated B cells, IgM+IgD–, per spleen. Error bars show SEM for 4–5 mice/time point. **P ≤ 0·01, ***P ≤ 0·0012
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Figure 4 Germinal centre cells expand substantially in the second infection. Mice were infected and some were treated with chloroquine (CQ) days 30–34. Two months later (d60), they 
were re-infected and analysed (2o d7). Splenocytes were stained and analysed by FACS for (a–c) CD19-TC, GL7-FITC and I-Ab (MHCII)-PE or (d–f) CD19-APC, CD38-FITC and 
IgD-biotin. (a, d) Plots are gated on lymphocytes and CD19+ as shown in Figure 1c. (b) Percent GL7+MHCII++ of CD19+ germinal centre B cells. (c) Expansion of Germinal 
centre cells is seen from the numbers of CD19+GL7+MHCII++ cells d0, d7, d60 (d0 2°), and d7 of the second infection. (e) Proportion and (f) number of germinal centre B cells, CD38− 
IgD− of CD19. Plots are representative of ﬁve mice. Error bars show SEM for 4–5 mice/time point. *P ≤ 0·05, **P ≤ 0·01, ***P ≤ 0·001, ns = not signiﬁcantly different, 2° = secondary.
Figure 5 Less CD23 down-regulation in second infection and expansion of Marginal Zone B cells. Mice were infected and some were treated with chloroquine (CQ) days 30–34 
post-infection. Two months post-infection, they were re-infected and analysed 7 days later (2o d7). (a) Splenocytes were stained and analysed by FACS for CD19-TC and IgD-FITC, 
and CD23-biotin on day 7 of the primary and secondary infection. (b) Percent and (c) numbers of CD23-IgD-CD19+ cells. Error bars show SEM for 3–5 mice/time point.© 2009 The Authors 27
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More B220− − − − mature bone marrow plasma cells produced in 
second infection
To  determine whether the increase in germinal centre and
marginal zone activity corresponded with an increase in
mature plasma cell production on second infection, we
examined plasma cells in the spleen and bone marrow (BM)
of infected mice. In agreement with our previous ﬁndings
(12), there was a large transient increase in splenic plasma
cells, which expressed high levels of Syndecan-1 (CD138) as
well as intracellular IgG or IgM (iIgG/M) (32) (gated as
shown in Figure 6a), in the acute phase of primary infection
(Figure 6b), peaking during acute infection and returning to
levels of uninfected controls by day 60. The antibody used
to detect intracellular antibody in plasma cells recognizes
both IgG and IgM, however, we do not suggest that these
isotypes can be expressed simultaneously. However, at day 7
of re-infection, plasma cell expansion was not observed in
the spleen (Figure  6b). Plasma cell numbers in the bone
marrow show a twofold loss of CD138hi plasma cells at the
peak of infection (Figure  6c), corresponding with overall
loss of bone marrow cells. But strikingly, more bone marrow
plasma cells are apparent at day 7 of the second infection
than in the ﬁrst. Chloroquine treatment had no signiﬁcant
effect on total number of plasma cells in spleen or BM at
day 60 of primary infection.
In order to characterize the plasma cell subpopulations in
the spleen and BM in P. chabaudi, we examined the expres-
sion of CD9 and B220 on CD138hi, intracellular IgG/Mhi
plasma cells. Syndecan-1+ plasma cells can be either short-lived
antibody producing cells (B220+), long-lived mature plasma
cells (B220−), or their precursors (B220+) (33–35). CD9 is
present on plasma cells from both T-dependent and thymus
independent (TI-2) responses in C57Bl/6 mice (36).
Plasma cells in the spleen and BM, deﬁned as CD138hi,
iIgM/IgGhi, and gated as shown in Figure 6(a), expressed
CD9; however, the proportion expressing B220 clearly
differed in the two organs and throughout infection. The
majority of the plasma cells in the spleen expressed B220
(68% average, day 7 Figure  a,b; left panel, B220+CD9+
gated, 0·6% of splenocytes). In the BM, B220− plasma cells
were  the majority (Figure  7a,b and 0·2% bone marrow
cells). In the ﬁrst infection, most plasma cells were produced
in the spleen, and only B220+ plasma cells increased in
numbers (Figure  7c). Naïve mice also have a majority of
B220+  plasma cells in the spleen and B220- in the bone
marrow, and percentages of total plasma cells in the bone
marrow do not change dramatically, due to tight constraints
on the availability of niches (34). By contrast, in the second
infection there was no expansion of plasma cells in the
spleen, but rather a decrease in numbers compared with
uninfected controls (P  =  0·01). In the bone marrow,
reduction of plasma cells was much less marked upon re-
challenge than in the primary (Figure 7d). There were more
mature B220− (P = 0·0002) and total plasma cells (P = 0·03)
present at day 7 of the second infection compared with the
primary infection day 7 (Figure 7d), suggesting that the
primary infection generates memory B cells that produce
plasma cells on re-infection. Chloroquine treatment resulted
in a small but signiﬁcant reduction in the number of total
plasma cells (P = 0·02 t-test) as well as B220- plasma cells in
spleen on reactivation (P = 0·002  t-test), and on total
Figure 6 Second infection gives rise to fewer splenic and more bone 
marrow plasma cells. Mice were infected and some groups were 
treated with Chloroquine (CQ). Two months post-infection (d60) 
they were re-infected (2o) and analysed for plasma cells. (a, b) 
splenocytes or (c) BM cells were stained for CD138-PE, 
intracellular anti-IgG+IgM-FITC, B220-APC, CD9-biotin. Density 
plot gated on live cells, excluding granulocytes. (a) Representative 
plot of splenocytes day 7 post-infection. Numbers of plasma cells 
(b) per spleen or (c) two legs. Error bars show SEM for 3 (d60) or 
5 mice/time point. **P ≤ 0·01, *** P ≤ 0·001, ns = not signiﬁcantly 
different.28 © 2009 The Authors
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(P = 0·03  t-test) but not B220−  plasma cells in the BM
(Figure 7d), conﬁrming that the B220− subset is not affected
by antigen persistence.
DISCUSSION
Here we have shown that B cells with memory cell charac-
teristics are generated after a single infection of the malaria
parasite, P. chabaudi. These CD19+ cells do not express IgD,
CD21 or CD23, though they do express CD38 indicating
that they are resting memory cells (29). These surviving cells
are either IgM+  or isotype switched, some expressing
IgG2a+ or IgG1+. Various subsets of B cells expand rapidly
on re-infection. Germinal centre B cells expand dramatically
in the ﬁrst week after re-infection and isotype-switched B
cells expand, although cells with the phenotype of IgM+
memory cells do not. Marginal Zone B cells also expand, as
would be expected from a population reported to contain
memory B cells. In addition, despite the large increase in
immature B220+ plasma cells in the spleen in the primary
infection, the second infection saw fewer of these produced.
There were almost no immature, B220+, plasma cells generated
in the second infection, but an increase in bone marrow
plasma cells suggests an improved response. These observa-
tions are in line with our previous work that demonstrated
both faster and greater serum IgG responses to speciﬁc
parasite antigens following re-infection and that serum
levels of speciﬁc antibody are maintained for 8 months post-
infection (15). The plasma cells and memory-phenotype
cells measured here are probably the cells responsible for the
anamnestic responses measured in these antigen-speciﬁc
assays.
A recent report has shown the presence of memory-
phenotype B cells to day 40 post-infection (11). Our results
support and extend this observation by showing that they
survive day 60 post-infection. Looking at a second infection
to test the functionality of memory B cells on re-stimulation,
we have shown that the B cell response in the second infection
has increased kinetics of activation and identiﬁed the
marginal zone and the germinal centre B cells as the
Figure 7 Second infection generates mature bone marrow plasma cells. Mice were infected and some treated with Chloroquine (CQ). Two 
months post-infection (d60) they were re-infected and analysed for plasma cells (2o d7). (a–d) Spleens and BM cells were stained for 
CD138-PE, intracellular anti-IgG+IgM-FITC, B220-APC, CD9-biotin. (a) Plots gated on live cells, excluding granulocytes, and all plasma 
cells, which are intracellular IgG+Mhi and CD138hi, or (b) ﬁrst gated on B220+CD9+ for splenocytes or B220−CD9+ for bone marrow, for a 
plot of the predominant plasma cell type. Numbers on plots represent percent of live cells in region (c, d) Total plasma cell numbers and 
B220− mature plasma cells are shown. Plots are representative of 5 mice at all time points, and error bars represent SEM. *P ≤ 0·05, **P ≤ 0·01, 
***P ≤ 0·001, ns = not signiﬁcantly different.© 2009 The Authors 29
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location for memory B cell activation. We have also shown
in previous work that speciﬁc antibody production is
improved in second infection (15), as would be expected
from functional memory B cells. Furthermore, we have
shown important differences in bone marrow plasma cell
production between the primary and secondary responses,
which make the memory response more efﬁcient.
In this study we have observed both IgM− and IgM+CD19+
memory B cells in the spleen, which do not express IgD,
CD21 or CD23, and do express CD38. A proportion of the
IgM− cells may be isotype-switched memory B cells, and in
line with this, the IgM− B cells expanded on re-infection.
Interestingly, an IgM+  subset of B cells with phenotypic
markers of memory cells (IgD−CD21−CD23−) was also
persistent, suggesting that in this infection there are IgM+
memory B cells (37). The phenotype resembles IgM+ memory
cells reported in human (37) or marginal zone cells. However,
on re-infection, these IgM + B cells either switched isotype,
becoming unrecognizable, or did not expand after a second
infection. The IgM+ memory cells we see here also resemble
T-I memory B cells (CD19+CD23−CD21−IgM+), which
unlike their IgG+  counterparts, do not expand on re-
challenge in the presence of antigen-speciﬁc IgG (31), as we
see here (Figure 4c). Both the IgM+ and IgM− memory
subsets do not express CD21/35. This down-regulation of
CR1/2 has also been described in P. falciparum infection (in
humans, complement receptor 1). It is of interest then that
haematin, a malaria parasite product, induces C3 degradation
and deposition, and that its concentration correlates with
surface expression of CR1 on B cells (38). CD21 has also
been reported to be down-regulated after binding to
complement-coated pathogen in HIV infections (39).
Our data shows a short-lived expansion of B220 + splenic
plasma cells followed by re-population of the BM by a
majority of mature B220− plasma cells, suggesting that a
fraction of the response is short-lived (35). The bone
marrow, during the acute phase of a primary infection, in
contrast to the spleen, has reduced numbers of total cells
and plasma cells. It has previously been reported that P. yoelli
infection results in loss of bone marrow plasma cells generated
by vaccination (14). This may be as a result of apoptosis in
situ,  or mobilization of resident plasma cells to sites of
inﬂammation such as the spleen (40). In the second infection
there was signiﬁcantly less splenomegaly, less B cell expansion
and fewer plasma cells in the spleen than during the acute
primary infection. Similarly, bone marrow cellularity is
not as reduced as it is in the primary response and more
terminally differentiated B220−  plasma cells remained,
suggesting that the large B cell response in a primary
infection contained memory B cells that expanded on re-
infection to produce plasma cells. It is likely that it is these
cells, together with low-level re-stimulation and differentiation
of memory B cells that maintain the serum antibody levels
seen up to eight months in this infection (15). Direct studies
of plasma cell longevity are currently underway. This could
be critical for immunity to re-infection, as BM plasma cells,
having undergone signiﬁcant selection, are more likely to
produce the high afﬁnity, neutralizing antibodies important
for clearance of the parasite.
Throughout this study, small but signiﬁcantly greater B
cell responses were observed in the second infection of
chronically infected mice, with more GL7 + (GC) B cells,
and more BM and splenic plasma cells generated compared
with drug-treated mice (Figures 4 and 7). These differences
cannot be attributed directly to parasite numbers in the
second infection, as they are lower in chronically and
re-infected mice (15). Therefore, our data suggest that at
some level, the presence of persistent parasites, and/or the
prolonged presence of antigens from dead parasites,
enhances the memory B cell compartment.
In conclusion, we have shown that the B cell response to
a second infection is more efﬁcient than the primary
response, the deﬁnition of adaptive immune memory.
Germinal centre B cells, marginal zone, and BM plasma cell
populations increase with enhanced kinetics. The faster
secondary B cell response, together with reduced splenomegaly
and less overall B cell activation, suggests that the B cell
response in the second infection is more focused or efﬁcient.
The next steps will be to determine whether enhanced
responsiveness and changes in B cell and plasma cell pheno-
types in spleen and bone marrow reﬂect the malaria-antigen
speciﬁc response.
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article:
Figure S1 Time-course of parasitaemia and cell numbers. These drawings show the course of parasitaemia and expansion of
splenocytes and B cells in the spleen, as measured by ﬂow cytometry of CD19 + cells. They represent data summarized from
Achtman et al. (2007).
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